361 resultados para ESTREPTOCOCO MUTANS


Relevância:

20.00% 20.00%

Publicador:

Resumo:

La infección por estreptococo del grupo B (GBS) es la principal causa de infección bacteriana y mortalidad por sepsis en los recién nacidos. La transmisión hacia el producto se da durante el trabajo de parto, a más de la mortalidad neonatal las secuelas neurológicas son importantes consecuencias de la infección por GBS, por lo tanto la detección y tratamiento oportuno debe realizarse en forma rutinaria. El objetivo de la presente investigación, es detectar la prevalencia de infección por GBS en embarazadas entre 34 a 41 semanas, y los factores que podrían estar asociados a la infección. En el presente estudio la prevalencia encontrada de EGB fue del 15,9. Los factores de riesgo mas importantes encontrados fueron: la edad de 19 a 35 años, el estado civil casada, vivir en medio urbano, la ocupación quehaceres domésticos, el inicio de vida sexual temprana, tener mas de 1 compañero sexual, la multiparidad antecedente de infección urinaria en el embarazo. El hecho de mantener relaciones anales u orales no fue causa significativa de infección de EGB

Relevância:

10.00% 10.00%

Publicador:

Resumo:

The aim of this case-control study of 617 children was to investigate early childhood caries (ECC) risk indicators in a non-fluoridated region in Australia. ECC cases were recruited from childcare facilities, public hospitals and private specialist clinics to source children from different socioeconomic backgrounds. Non-ECC controls were recruited from the same childcare facilities. A multinomial logistic modelling approach was used for statistical analysis. The results showed that a large percentage of children tested positive for Streptococcus mutans if their mothers also tested positive. A common risk indicator found in ECC children from childcare facilities and public hospitals was visible plaque (OR 4.1, 95% CI 1.0-15.9, and OR 8.7, 95% CI 2.3-32.9, respectively). Compared to ECC-free controls, the risk indicators specific to childcare cases were enamel hypoplasia (OR 4.2, 95% CI 1.0-18.3), difficulty in cleaning child's teeth (OR 6.6, 95% CI 2.2-19.8), presence of S. mutans (OR 4.8, 95% CI 0.7-32.6), sweetened drinks (OR 4.0, 95% CI 1.2-13.6) and maternal anxiety (OR 5.1, 95% CI 1.1-25.0). Risk indicators specific to public hospital cases were S. mutans presence in child (OR 7.7, 95% CI 1.3-44.6) or mother (OR 8.1, 95% CI 0.9-72.4), ethnicity (OR 5.6, 95% CI 1.4-22.1), and access of mother to pension or health care card (OR 20.5, 95% CI 3.5-119.9). By contrast, a history of chronic ear infections was found to be protective for ECC in childcare children (OR 0.28, 95% CI 0.09-0.82). The biological, socioeconomic and maternal risk indicators demonstrated in the present study can be employed in models of ECC that can be usefully applied for future longitudinal studies.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Background Home visits (HV) provide excellent opportunities for health promotion. Aim This longitudinal study compared the effects of HV and telephone contacts (TC) in preventing early childhood caries (ECC) and colonisation of mutans streptococci (MS) and lactobacilli (LB) from 0 to 24 months. Design A total of 325 children were recruited from community health centres at mean age of 42 days, and randomly assigned to receive either HV or TC. A total of 188 children completed three, 6 monthly HV, and another 58 had three, 6 monthly TC. An additional 40 age-matched children from childcare facilities served as reference controls (RC). At 24 months, all groups were examined at a community dental clinic. Results At 24 months, three HV children of 188 (1.5%) had caries, compared to four TC of 58 (6.8%) and nine RC of 40 (22.5%) (P < 0.001 for HV versus RC; P = 0.05 for HV versus TC and P = 0.03 for TC versus RC). There were also more children with MS in the TC (47%) and RC (35%) compared to HV (28%) group (P = 0.01 and P = 0.02). Conclusions Home visits and telephone contacts conducted 6 monthly from birth are effective in reducing ECC prevalence by 24 months.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

PURPOSE: The purpose of this study was to compare twice daily tooth-brushing using 0.304 percent fluoride toothpaste alone with: (1) twice daily tooth-brushing plus once daily 10% casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) paste; and (2) twice daily tooth-brushing plus once daily 0.12% chlorhexidine gel (CHX) for reducing early childhood caries (ECC) and mutans streptococci (MS) colonization. METHODS: Subjects (n=622) recruited at birth were randomized to receive either CPP-ACP or CHX or no product (study control [SC]). All children were examined at 6, 12, and 18 months old in their homes, and at 24 months old in a community dental clinic. RESULTS: At 24 months old, the caries incidence was 1% (2/163) in CPP-ACP, 2% (4/180) in CHX, and 2% (3/188) in SC groups. In children who were previously MS colonized at 12 and 18 months old, 0% (0/11) and 5% (3/63), respectively, of the CPP-ACP group remained MS-positive versus 22% (2/9) and 72% (18/25) in CHX and 16% (4/25) and 50% (7/14) in SC groups (P<.001). CONCLUSIONS: There is insufficient evidence to justify the daily use of casein phosphopeptide-amorphous calcium phosphate or chlorhexidine gel to control early childhood caries.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Objectives This randomised, controlled trial compared the effectiveness of 0.12% chlorhexidine (CHX) gel and 304% fluoride toothpaste to prevent early childhood caries (ECC) in a birth cohort by 24 months. Methods The participants were randomised to receive either (i) twice daily toothbrushing with toothpaste and once daily 0.12% CHX gel (n = 110) or (ii) twice daily toothbrushing with toothpaste only (study controls) (n = 89). The primary outcome measured was caries incidence and the secondary outcome was percentage of children with mutans streptococci (MS). All mothers were contacted by telephone at 6, 12, and 18 months. At 24 months, all children were examined at a community dental clinic. Results At 24 months, the caries prevalence was 5% (3/61) in the CHX and 7% (4/58) in the controls (P = 0.7). There were no differences in percentages of MS-positive children between the CHX and control groups (54%vs 53%). Only 20% applied the CHX gel once daily and 80% less than once daily. Conclusions Toothbrushing using 304% fluoride toothpaste with or without the application of chlorhexidine gel (0.12%) reduces ECC from 23% found in the general community to 5–7%. The lack of effect with chlorhexidine is likely to be due to low compliance.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

The purpose of this study was to establish a three-dimensional fluorescent tooth model to investigate bacterial viability against intra-canal medicaments across the thickness and surface of root dentine. Dental microbial biofilms (Enterococcus faecalis and Streptococcus mutans) were established on the external root surface and bacterial kill was monitored over time against intra-canal medicament (Ca(OH)2 ) using fluorescent microscopy in conjunction with BacLight SYTO9 and propidium iodide stains. An Olympus digital camera fitted to SZX16 fluorescent microscope captured images of bacterial cells in biofilms on the external root surface. Viability of biofilm was measured by calculating the total pixel area of green (viable bacteria) and red (non-viable bacteria) for each image using ImageJ® software. All data generated were assessed for normality and then analysed using a Mann-Whitney t-test. The viability of S. mutans biofilm following Ca(OH)2 treatment showed a significant decline compared with the untreated group (P = 0.0418). No significant difference was seen for E. faecalis biofilm between the Ca(OH)2 and untreated groups indicating Ca(OH)2 medicament is ineffective against E. faecalis biofilm. This novel three-dimensional fluorescent biofilm model provides a new clinically relevant tool for testing of medicaments against dental biofilms.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

New ternary copper (II) complexes, Cu(L-orn)(B)(Cl)](Cl center dot 2H(2)O) (1-2) where L-orn is L-ornithine, B is an N,N-donor heterocyclic base, viz. 2,2'-bipyridine (bpy, 1) and 1,10-phenanthroline (phen, 2), were synthesized and characterized by various spectroscopic techniques. Complex 2 is characterized by the X-ray single crystallographic method. The complex shows a distorted square-pyramidal (4 + 1) CuN3OCl coordination sphere. Binding interactions of the complexes with calf thymus DNA (CT-DNA) were investigated by UV-Vis absorption titration, ethidium bromide displacement assay, viscometric titration experiment and DNA melting studies. Complex 2 shows appreciable chemical nuclease activity in the presence of 3-mercaptopropionic acid (MPA). The complexes were subjected to in vitro cytotoxicity studies against carcinomic human alveolar basal epithelial cells (A-549) and human epithelial (HEp-2) cells. The IC50 values of 1 and 2 are less than that of cisplatin against HEp-2 cell lines. MIC values for 1 against the bacterial strains Streptococcus mutans and Pseudomonas aeruginosa are 0.5 mM. (C) 2012 Elsevier Ltd. All rights reserved.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

El presente trabajo se realizó entre los meses de Junio a Noviembre de 1966, en los laboratorios de la Escuela Nacional de Agricultura y Ganadería. Se uso la prueba de bromotimol azul para prueba presuntiva de mastitis. Nueve fincas fueron examinadas. Las muestras de leche positivas a la prueba de bromotimol azul se sometieron a examen de laboratorio. En este estudio se dio énfasis en determinar la prevalencia de mastitis para el departamento de Managua, en observar las bacterias causantes de mastitis y el aislamiento de estreptococo hemolítico. Los resultados obtenidos en este trabajo fueron: 1). De 926 vacas examinadas salio 12.50% positivas; 7.13% sospechosas y el 80.34% negativas. 2). De 7,304 cuartos examinados resultaron 211 positivos, 176 sospechosos y 3,317 libres de infección. 3). Entre las razas, la Guernsey es la que aparece con el mayor porcentaje de prevalescencia con 17.92 seguida por la Holstein con 17.64 cruce con 14.28, Pardo Suizo con 11.49, Criolla con 7.23 y la Red Pool con 0. 4). De 116 muestras de leche tomadas de vacas positivas, según el examen de laboratorio, el 50.86% tenían estafilococo hemolítico, 30.18% formas bacilares y el 18.96% mostraban las formas anteriores. 5). El estreptococo hemolítico no se encontró.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Objetivo. O objetivo do presente estudo foi avaliar o efeito da incorporação de diacetato de clorexidina (CDA), em diferentes concentrações e tempos de armazenamento, nas propriedades físicas e na atividade antibacteriana de resinas acrílicas, utilizadas na confecção de coroas e pontes provisórias. Métodos. Fase I: Foram confeccionados 150 corpos de prova retangulares (3,0 mm X 10 mm X 64 mm), de acordo com a norma ISO 1567 e 150 corpos de prova quadrados (10 mm X 10 mm X 2,0 mm), utilizando-se duas resinas acrílicas autopolimerizáveis, Duralay (Reliance Dental Mfg. Co.) e Dencor (Clássico). Os corpos de prova foram distribuídos em 30 grupos (n=10/grupo) de acordo com a concentração de CDA incorporada às resinas (p/p) (A) 0%, (B) 1%, (C) 2%, (D) 4%, (E) 5%, em função do tempo de armazenamento em água destilada, a 37C (T0 2h, T1 7 dias, T2 30 dias). Foram realizados os ensaios de microdureza Knoop, em microdurômetro Micromet 5104, Buehler (N), rugosidade superficial (Ra), em rugosímetro digital Mitutoyo Surftest SJ-201 (n=5) e resistência à flexão em três pontos (MPa), em uma máquina de ensaio universal EMIC MF 200 DL (n=5). Fase II: Adicionalmente, a atividade antibacteriana dos materiais sobre Streptococcus mutans foi determinada através da realização de testes de difusão em meio BHI, sendo para isso confeccionados 30 corpos de prova em forma de disco (12 mm X 3,0 mm) com as mesmas 5 concentrações (n=3/grupo). Os resultados foram tabulados e submetidos à análise estatística three-way ANOVA (Fase I) e two-way ANOVA (Fase II). Resultados. ANOVA mostrou que a adição de CDA não provocou alteração significativa na resistência à flexão dos materiais testados. A resistência à flexão é inversamente proporcional ao tempo para a resina Dencor e diretamente proporcional ao tempo para a resina Duralay. Houve aumento da microdureza com o acréscimo de CDA ao material Dencor com relação ao grupo controle, enquanto que no material Duralay a CDA não interferiu significativamente nesta propriedade. A rugosidade superficial aumentou significativamente (p<0,001) com o tempo e com o aumento da concentração de clorexidina na resina Dencor e não provocou alteração significativa em Duralay. Os testes de difusão em ágar demonstraram atividade antimicrobiana significativa (p<0,05) em todos os grupos, quando comparados ao grupo-controle. A inibição ao crescimento de Streptococcus mutans foi maior com o aumento da concentração desta substância. A resina Dencor apresentou maior halo de inibição do que a resina Duralay. Conclusões. Os resultados deste estudo sugerem que a incorporação de clorexidina aos materiais testados exibiu efeito antibacteriano contra S. mutans, sem contudo afetar de maneira crítica as propriedades físicas avaliadas.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

O objetivo deste trabalho foi o de avaliar in vitro o efeito da ação antibacteriana de cimentos de ionômero de vidro (CIVs) convencionais incorporados com diacetato de clorexidina (DCHX) sobre o Streptococcus mutans. Foram testados os CIVs Maxxion R e Vitro Fil R com a incorporação dos percentuais de 0,5%, 1% e 2% de DCHX através de difusão em ágar e pela exaustão do DCHX por até 40 dias, a fim de observar a longevidade de sua ação inibitória. Foi também avaliado o efeito do fluoreto de sódio na ação antibacteriana do DCHX. Para determinar a diferença entre a média dos halos de inibição Os resultados foram analisados por análise de variância e pelo teste Student-Newman-Keuls (SNK). Todos os corpos de prova com DCHX apresentaram halo para os CIVs variando de 2,29mm a 6,82mm para o Maxxion R e de 1,73mm a 8,97mm para o Vitro Fil R. A capacidade de inibição foi proporcional à concentração de DCHX. Através do teste SNK apenas os grupos Vitro Fil R 0,5% e1% não variaram significativamente entre si. O 15o dia foi o de maior atividade antibacteriana para ambos os CIVs. Os grupos Maxxion R 1% e 2% foram os que menos apresentaram diferenças ao longo do tempo. Não houve crescimento de S mutans para os períodos de 7 e 15 dias de exaustão, sendo verificado o crescimento de colônias apenas na superfície do meio após o período de 96hs de incubação. Não foi observado efeito antagônico na capacidade antibacteriana do DCHX na presença de fluoreto de sódio. A incorporação de DCHX aos CIVs Maxxion R e Vitro Fil R, nas concentrações testadas e por um período de até 40 dias, apresentam resultados positivos no controle bacteriano de S mutans. Dentro das limitações deste estudo é lícito concluir que: efeito da inibição ao S mutans é dependente da concentração do DCHX; o fluoreto por si só não é capaz de inibir o crescimento de S mutans; a associação do DCHX com os CIVs não alterou a capacidade da ação antibacteriana da CHX; a ação antibacteriana da CHX incorporada aos CIVs se mantém eficaz por 15 dias, independente do CIV testado.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Estreptococos do grupo B (EGB), principalmente sorotipo III são a principal causa de pneumonia neonatal, sepse e meningite. O potencial de virulência das amostras de EGB pode determinar a colonização ou a infecção do hospedeiro. Como o pulmão constitui uns dos primeiros órgãos durante o processo de invasão sistêmica por EGB, nós decidimos investigar os mecanismos de adesão e invasão de amostras do sorotipo III (90356-líquor e 80340-vagina) com linhagem de células epiteliais do pulmão humano (A549). Desta forma, o principal objetivo deste estudo foi avaliar a capacidade de aderência e invasão de duas amostras de EGB sorotipo III com células de epiteliais pulmonares A549, a persistência bacteriana intracelular, a fusão com compartimentos acídicos, potencial citotóxico e indução de apoptose. As amostras mostraram capacidade de aderir e invadir o epitélio pulmonar A549, onde a amostra 90356-líquor isolada de paciente a que apresentou maior propriedade adesiva e invasiva que a amostra 80340-vagina (p<0,05). Ambas as cepas mostraram persistência intracelular sem replicação no interior do epitélio respiratório até 24h de incubação. Além disso, verificamos que os EGB são capazes de promover vacuolização celular permanecendo viáveis dentro de vacúolos acídicos, sugerindo a ocorrência de fusão lisossomo-fagossomo. A amostra 90356-líquor também mostrou maior citotoxidade quando comparada com a amostra 80340-vagina. A análise por citometria de fluxo demonstrou, pela primeira vez, que o EGB induz apoptose em epitélio respiratório, podendo representar um mecanismo importante para o desenvolvimento da lesão celular aguda e a patogênese bacteriana.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Projeto de Pós-Graduação/Dissertação apresentado à Universidade Fernando Pessoa como parte dos requisitos para obtenção do grau de Mestre em Ciências Farmacêuticas

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Many neuropeptides are similar in size, amino acid composition and charge to antimicrobial peptides. This study aimed to determine whether the neuropeptides substance P (SP), neurokinin A (NKA), calcitonin gene-related peptide (CGRP), neuropeptide Y (NPY) and vasoactive intestinal polypeptide (VIP), displayed antimicrobial activity against Streptococcus mutans, Lactobacillus acidophilus, Enterococcus faecalis, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans. SP, NPY, VIP and CGRP displayed variable degrees of antimicrobial activity against all the pathogens tested with the exception of S. aureus. These antimicrobial activities add a further dimension to the immunomodulatory roles for neuropeptides in the inflammatory and immune responses. (c) 2008 Elsevier B.V. All rights reserved.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

A study was undertaken to examine the population structure of viridans group streptococci (VGS) in the sputum of adult patients with cystic fibrosis (CF). Freshly expectorated sputa (n=58) from 45 adult CF patients were examined by selective conventional culture on Mitis-Salivarius agar and yielded 190 isolates of VGS. Sequence analyses of the rpnB and 16-23S rRNA ITS genes identified these isolates to belong to 12 species of VGS and included S. anginosus, S. australis, S. cristatus, S. gordonii, S. infantis, S. mitis, S. mutans, S. oralis, S. parasanguinis, S. pneumoniae, S. salivarius and S. sanguinis. The most frequently VGS organism isolated was S. salivarius (47/190; 24.7%), followed by S. mitts (36/190; 19%), S. sanguinis (25/190; 13.2%), S. oralis (20/190; 11.0%), S. pneumoniae (19/190; 10.0%), S. parasanguinis (16/190; 8.4%), S. infantis (11/190; 5.8%), S. gordonii (7/190; 3.7%), S. anginosus (4/190; 2.1%), S. cristatus (2/190; 1.1%), S. australis (1/190; 0.5%), S. mutans (1/190; 0.5%) and S. agalactiae (1/190; 0.5%). All, but four, patients harboured at least one VGS species, which ranged from one to five streptococcal species, with a mean of 2.85 species per patient. There was no clonality at the subspecies level employing ERIC RAPD PCR. Antibiotic susceptibility was determined by Minimum Inhibitory Concentration (MIC) testing against penicillin, erythromycin and ciprofloxacin. Overall, resistance to penicillin with all VGS was 73/190 (38.4%) and 167/190 (87.9%) for erythromycin. With regard to ciprofloxacin, 27/190 (14.2%) were fully resistant, whilst a further 21/190 (11.1%) showed intermediate resistance, which equated to approximately three quarters (74.7%) of isolates being fully sensitive to this agent. In addition, as a comparator control population, we examined antibiotic susceptibility, as above, in a non-CF population comprising 12 individuals (50 VGS isolates), who were not receiving chronic antibiotics. In comparison, 8% and 38% of VGS isolates from non-CF individuals were resistant by disk susceptibility testing to penicillin and erythromycin, respectively. None of the non-CF VGS organisms were resistant to ciprofloxacin, but 42% showed intermediate resistance. (C) 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Cationic amphipathic α-helical peptides are intensively studied classes of host defence peptides (HDPs). Three peptides, peptide glycine-leucine-amide (PGLa-AM1), caerulein-precursor fragment (CPF-AM1) and magainin-AM1, originally isolated from norepinephrine-stimulated skin secretions of the African volcano frog Xenopus amieti (Pipidae), were studied for their antimicrobial and immunomodulatory activities against oral and respiratory pathogens. Minimal effective concentrations (MECs), determined by radial diffusion assay, were generally lower than minimal inhibitory concentrations (MICs) determined by microbroth dilution. PGLa-AM1 and CPF-AM1 were particularly active against Streptococcus mutans and all three peptides were effective against Fusobacterium nucleatum, whereas Enterococcus faecalis and Candida albicans proved to be relatively resistant micro-organisms. A type strain of Pseudomonas aeruginosa was shown to be more susceptible than the clinical isolate studied. PGLa-AM1 displayed the greatest propensity to bind lipopolysaccharide (LPS) from Escherichia coli, P. aeruginosa and Porphyromonas gingivalis. All three peptides showed less binding to P. gingivalis LPS than to LPS from the other species studied. Oral fibroblast viability was unaffected by 50. μM peptide treatments. Production of the pro-inflammatory cytokine IL-8 by oral fibroblasts was significantly increased following treatment with 1 or 10. μM magainin-AM1 but not following treatment with PGLa-AM1 or CPF-AM1. In conclusion, as well as possessing potent antimicrobial actions, the X. amieti peptides bound to LPS from three human pathogens and had no effect on oral fibroblast viability. CPF-AM1 and PGLa-AM1 show promise as templates for the design of novel analogues for the treatment of oral and dental diseases associated with bacteria or fungi.